Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of BMS-986089 in Ambulatory Boys With Duchenne Muscular Dystrophy
Diseases of the Musculoskeletal System | Genetics - Pediatric
What is the purpose of this trial?
This is a multi-center, randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability of two different weekly doses of BMS-986089 in ambulatory boys with Duchenne Muscular Dystrophy (DMD).
- Ages6 - 11 years
- GenderMale only
- Trial withBristol-Myers Squibb Research and Development
- Start Date05/30/2018
- End Date07/29/2020
- Last Updated06/05/2018
- Study HIC#2000021057